Compare peptides
Put two entries side by side — evidence, mechanism, risks, and community claims.
Glucagon
Clinical
FDA-approved (specific use)
Summary
Endogenous peptide hormone raising blood glucose; medical rescue drug and component of dual/triple agonist design.
Categories
Metabolic & Body Comp
Mechanism
Glucagon receptor activation in liver promotes glycogenolysis and gluconeogenesis; also affects satiety and energy expenditure pathways in drug design.
Half-life
Minutes
Routes
Intramuscular injection; Subcutaneous injection; Intranasal; Intravenous
Legal / access
Approved emergency and medical products exist; research misuse is inappropriate.
Key risks
- Nausea
- Vomiting
- Tachycardia
- Hyperglycemia
Common claims
- Metabolic flexibility
- Part of triple-agonist hype
Select peptide B